Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Cash (2016 - 2025)

Historic Change in Cash for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $28.6 million.

  • Amphastar Pharmaceuticals' Change in Cash rose 104441.33% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.1 million, marking a year-over-year increase of 13069.03%. This contributed to the annual value of $7.3 million for FY2024, which is 16196.41% up from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Change in Cash is $28.6 million, which was up 104441.33% from $4.9 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Change in Cash high stood at $119.8 million for Q3 2023, and its period low was -$126.5 million during Q4 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Change in Cash value was $4.9 million (recorded in 2025), while the average stood at $6.4 million.
  • Over the last 5 years, Amphastar Pharmaceuticals' Change in Cash had its largest YoY gain of 144362.17% in 2023, and its largest YoY loss of 1093891.8% in 2023.
  • Amphastar Pharmaceuticals' Change in Cash (Quarter) stood at $19.7 million in 2021, then tumbled by 105.8% to -$1.1 million in 2022, then plummeted by 10938.92% to -$126.5 million in 2023, then soared by 67.98% to -$40.5 million in 2024, then skyrocketed by 170.55% to $28.6 million in 2025.
  • Its Change in Cash was $28.6 million in Q3 2025, compared to $4.9 million in Q2 2025 and $31.2 million in Q1 2025.